Thu, July 21, 2022
Wed, July 20, 2022
Tue, July 19, 2022

Yigal Nochomovitz Maintained (APLS) at Strong Buy with Increased Target to $86 on, Jul 20th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-86-on-jul-20th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Yigal Nochomovitz of Citigroup, Maintained "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy with Increased Target from $81 to $86 on, Jul 20th, 2022.

Yigal has made no other calls on APLS in the last 4 months.



There are 6 other peers that have a rating on APLS. Out of the 6 peers that are also analyzing APLS, 1 agrees with Yigal's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Tiago Fauth of "Credit Suisse" Maintained at Hold with Increased Target to $44 on, Thursday, May 5th, 2022


These are the ratings of the 5 analyists that currently disagree with Yigal


  • Douglas Tsao of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $75 on, Tuesday, July 19th, 2022
  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $84 on, Tuesday, May 24th, 2022
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Decreased Target to $102 on, Thursday, May 5th, 2022
  • Elemer Piros of "Roth Capital" Downgraded from Hold to Strong Sell and Held Target at $40 on, Thursday, April 14th, 2022
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $69 on, Monday, April 4th, 2022

Publication Contributing Sources